OOIR: Observatory of International Research

Papers

(The TQCC of European Journal of Paediatric Neurology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
E.U. paediatric MOG consortium consensus: Part 1 – Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders	97
E.U. paediatric MOG consortium consensus: Part 5 – Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders	64
Severe Neurological Impairment: A delphi consensus-based definition	57
Mid- and long-term (at least 12 months) follow-up of patients with spinal muscular atrophy (SMA) treated with nusinersen, onasemnogene abeparvovec, risdiplam or combination therapies: A systematic rev	52
CACNA1A-associated epilepsy: Electroclinical findings and treatment response on seizures in 18 patients	37
E.U. paediatric MOG consortium consensus: Part 2 – Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders	37
E.U. paediatric MOG consortium consensus: Part 4 – Outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders	34
Children and young adults with spinal muscular atrophy treated with nusinersen	32
Acute encephalitis in pediatric multisystem inflammatory syndrome associated with COVID-19	30
Lissencephaly in an epilepsy cohort: Molecular, radiological and clinical aspects	30
Lissencephaly: Update on diagnostics and clinical management	29
Melatonin for neuroprotection in neonatal encephalopathy: A systematic review & meta-analysis of clinical trials	29
Genetic causes underlying grey matter heterotopia	26
Evidence-based interventions for children and adolescents with fetal alcohol spectrum disorders – A systematic review	26
CDKL5 deficiency disorder in males: Five new variants and review of the literature	25
E.U. paediatric MOG consortium consensus: Part 3 – Biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders	24
A practical approach to prenatal diagnosis of malformations of cortical development	24
Extra-uterine growth restriction in preterm infants: Neurodevelopmental outcomes according to different definitions	22
GATOR1-related focal cortical dysplasia in epilepsy surgery patients and their families: A possible gradient in severity?	20
Amplitude and stride-to-stride variability of muscle activity during Lokomat guided walking and treadmill walking in children with cerebral palsy	19
Neurological presentations and cognitive outcome in Sturge-Weber syndrome	19
Revision of the diagnostic criteria of alternating hemiplegia of childhood	19
Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review	19
Clinical spectrum and treatment outcome of 95 children with continuous spikes and waves during sleep (CSWS)	18
Clinical phenotypes of infantile onset CACNA1A-related disorder	17

Nusinersen does not improve lung function in a cohort of children with spinal muscular atrophy – A single-center retrospective study	17
Usability and inter-rater reliability of the NeuroMotion app: A tool in General Movements Assessments	16
Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy	16
The bottom-up approach: Non-invasive peripheral neurostimulation methods to treat migraine: A scoping review from the child neurologist's perspective	16
The myth of vaccination and autism spectrum	15
Early initiation of ambroxol treatment diminishes neurological manifestations of type 3 Gaucher disease: A long-term outcome of two siblings	15
Continuing decline in the prevalence of cerebral palsy in Denmark for birth years 2008–2013	15
The prevalence and clinical relevance of hyperhomocysteinemia suggesting vitamin B12 deficiency in presumed healthy infants	14
Clinical features of paediatric and adult autoimmune encephalitis: A multicenter sample	14
Cerliponase alfa changes the natural history of children with neuronal ceroid lipofuscinosis type 2: The first French cohort	14
Ocrelizumab in pediatric multiple sclerosis	14
Epidemiology of traumatic brain injury in children 15 years and younger in South-Eastern Norway in 2015–16. Implications for prevention and follow-up needs	14
Clinical outcomes of pediatric Anti-NMDA receptor encephalitis	14
Long-term cardiovascular safety of fenfluramine in patients with Dravet syndrome treated for up to 3 years: Findings from serial echocardiographic assessments	14
A comparison of the early motor repertoire of very preterm infants and term infants	14
The phenotypic variability and natural history of NARS2 associated disease	13
Motor outcome after perinatal stroke and early prediction of unilateral spastic cerebral palsy	13
A recent surge of fulminant and early onset subacute sclerosing panencephalitis (SSPE) in the United Kingdom: An emergence in a time of measles	13
Cognitive and neurological outcome of patients in the Dutch pyridoxine-dependent epilepsy (PDE-ALDH7A1) cohort, a cross-sectional study	13
Cost-effectiveness of whole-exome sequencing in progressive neurological disorders of children	13
Is there a relationship between socioeconomic factors and prevalence, adherence and outcome in childhood epilepsy? A systematic scoping review	12
Health-related quality of life in children and adolescents with tuberous sclerosis complex and their caregivers: A multicentre cohort study from Germany	12
Pediatric recurrent acute necrotizing encephalomyelitis, RANBP2 genotype and Sars-CoV-2 infection: Diagnosis, pathogenesis and targeted treatments from a case study	12
Data-driven historical characterization of epilepsy-associated genes	12
A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors	12
Diagnosis of pediatric anti-NMDAR encephalitis at the onset: A clinical challenge	12
Change in cross-sectional area of the median nerve with age in neonates, infants and children analyzed by high-resolution ultrasound imaging	11
Deep brain stimulation in the management of paediatric neuropsychiatric conditions: Current evidence and future directions	11
Gait phenotype in Batten disease: A marker of disease progression	10
Self-limited focal epilepsy and childhood apraxia of speech with WAC pathogenic variants	10
Hemimegalencephaly and tuberous sclerosis complex: A rare yet challenging association	10
Acute-onset paralytic strabismus in toddlers is important to consider as a potential early sign of late-infantile Metachromatic Leukodystrophy	10
Pediatric SMA patients with complex spinal anatomy: Implementation and evaluation of a decision-tree algorithm for administration of nusinersen	10
Melatonin usage in children and young adults, a registry-based cohort study	10
Neonatal hypoxic-ischaemic encephalopathy: Motor impairment beyond cerebral palsy	10
Evaluating next-generation sequencing in neuromuscular diseases with neonatal respiratory distress	10
Adaptive skills and mental health in children and adolescents with neuromuscular diseases	10
Recessive VAMP1 mutations associated with severe congenital myasthenic syndromes – A recognizable clinical phenotype	9
Posterior Reversible Encephalopathy Syndrome in infants and young children	9
Quality of life and neurological disability in children and young people with ataxia telangiectasia	9
Rituximab in juvenile myasthenia gravis-an international cohort study and literature review	9
The impact of instrumented gait analysis on decision-making in the interprofessional management of cerebral palsy: A scoping review	9
CASK related disorder: Epilepsy and developmental outcome	9
Developmental neurobiology of cerebellar and Basal Ganglia connections	9
Relationship between resting-state fMRI functional connectivity with motor and language outcome after perinatal brain injury – A systematic review	9
Instrumented classification of patients with early onset ataxia or developmental coordination disorder and healthy control children combining information from three upper limb SARA tests	9
MECP2-related conditions in males: A systematic literature review and 8 additional cases	9
Functional outcomes of children with dyskinetic cerebral palsy depend on etiology and gestational age	9
Neurological disorders encountered in a pediatric emergency department	9
Effect of age, cerebral infarcts, vasculopathy and haemoglobin on cognitive function, in Tanzanian children with sickle cell anaemia	8

Dystonia assessment in children with cerebral palsy and periventricular leukomalacia	8
Safety and recommendations for vaccinations of children with inborn errors of metabolism	8
Endocrine and metabolic aspects of narcolepsy type 1 in children	8
Preoperative clinical symptomatology and stroke burden in pediatric moyamoya angiopathy: Defining associated risk variables	8
Neurocognitive profile of a cohort of SMA type 1 pediatric patients and emotional aspects, resilience and coping strategies of their caregivers	8
Characterization of sedation and anesthesia complications in patients with alternating hemiplegia of childhood	8
Implementation of Motor Function Measure score percentile curves - Predicting motor function loss in Duchenne muscular dystrophy	7
A Decision for Life – Treatment decisions in newly diagnosed families with spinal muscular atrophy (SMA)	7
Rehabilitation in childhood-onset hyperkinetic movement disorders including dystonia: Treatment change in outcomes across the ICF and feasibility of outcomes for full trial evaluation	7
Altered anterior insula functional connectivity in adolescent and young women with endometriosis-associated pain: Pilot resting-state fMRI study	7
Dystonia and choreoathetosis presence and severity in relation to powered wheelchair mobility performance in children and youth with dyskinetic cerebral palsy	7
The phenotypic spectrum of PCDH12 associated disorders - Five new cases and review of the literature	7
Migraine and epilepsy: Social cognition skills in pediatric population	7
Neonatal neurological examination in a resource-limited setting: What defines normal?	7
Neurofilament light chain: A novel blood biomarker in patients with ataxia telangiectasia	7
Crisis of confidence in vaccination and the role of social media	7
Pediatric vestibular migraine: Diagnosis according to ICHD-3 criteria and the effectiveness of short-term CH prophylaxis	7
The Unified Batten Disease Rating Scale (UBDRS): Validation and reliability in an independent CLN3 disease sample	7
Normal intellectual skills in patients with Rhombencephalosynapsis	7
Genetic testing in children enrolled in epilepsy surgery program. A real-life study	7
A vitamin a day keeps the doctor away: The need for high quality pyridoxal-5′-phosphate	6
Brain morphological abnormalities in children with cyclin-dependent kinase-like 5 deficiency disorder	6
Sleep in children with refractory epilepsy and epileptic encephalopathies: A systematic review of literature	6
Mineralizing angiopathy with basal ganglia stroke after minor head trauma; a clinical profile and follow up study of a large series of paediatric patients from North India	6
SCN1A-related epilepsy with recessive inheritance: Two further families	6
Early MRI diagnosis of Sturge Weber Syndrome type 1 in infants	6
Development of muscle tone impairments in high-risk infants: Associations with cerebral palsy and cystic periventricular leukomalacia	6
Endovascular and thrombolytic treatment eligibility in childhood arterial ischemic stroke	6
Clinical characteristics of paediatric Hashimoto's encephalopathy	6
Survival in patients diagnosed with SMA at less than 24 months of age in a population-based setting before, during and after introduction of nusinersen therapy. Experience from Sweden	6
Effects of antiseizure monotherapy on visuospatial memory in pediatric age	6
Natural history of TRPV4-Related disorders: From skeletal dysplasia to neuromuscular phenotype	6
Intranasal dexmedetomidine vs oral triclofos sodium for sedation of children with autism undergoing electroencephalograms	6
Exome sequencing and electro-clinical features in pediatric patients with very early-onset retinal dystrophies: A cohort study	6
CCL2/MCP-1, interleukin-8, and fractalkine/CXC3CL1: Potential biomarkers of epileptogenesis and pharmacoresistance in childhood epilepsy	6
Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome	6
Epidemiology of paediatric moderate and severe traumatic brain injury in the Netherlands	6
Fenfluramine responder analyses and numbers needed to treat: Translating epilepsy trial data into clinical practice	6
3T MRI signal intensity profiles and thicknesses of transient zones in human fetal brain at mid-gestation	6
Cognitive, academic, executive and psychological functioning in children with spastic motor type cerebral palsy: Influence of extent, location, and laterality of brain lesions	6
Prognostic value of brain abnormalities for cognitive functioning in cerebral palsy: A prospective cohort study	6
A novel ATP1A2 variant associated with severe stepwise regression, hemiplegia, epilepsy and movement disorders in two unrelated patients	6
The spectrum of acute leukoencephalopathy with restricted diffusion (ALERD): A case series and review of literature	6
Prevalence of cerebral palsy and factors associated with cerebral palsy subtype: A population-based study in Belgium	6
Repetitive neuromuscular magnetic stimulation in children with headache	6
Inflammatory markers in cerebrospinal fluid of paediatric spinal muscular atrophy patients receiving nusinersen treatment	6
Surgical complications of intrathecal baclofen in children: A single centre, 20-year retrospective cohort study	5
Investigations in children with seizures visiting a pediatric emergency department: A monocenter study	5
CNTNAP1-encephalopathy: Six novel patients surviving the neonatal period	5
Thiamine-responsive, life-threatening, pulmonary hypertensive crisis with encephalopathy in young infants: A case series	5
Age-dependent characteristics and prognostic factors of pediatric anti-N-methyl-d-aspartate receptor encephalitis in a Chinese single-center study	5
Abnormal heart rate variability at school age in survivors of neonatal hypoxic-ischemic encephalopathy managed with therapeutic hypothermia	5
Guardians of the epilepsy genome	5
The phenotype of homozygous EMC10 variant: A new syndrome with intellectual disability and language impairment	5
Giant pattern VEPs in children	5
Tremor-like subcortical myoclonus in STXBP1 encephalopathy	5
Mitochondrial diseases mimicking autoimmune diseases of the CNS and good response to steroids initially	5
Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study	5
Functional brain maturation and sleep organisation in neonates with congenital heart disease	5
Long-term outcomes of very-low-birth-weight and low-birth-weight preterm newborns with neonatal seizures: A single-center perspective	5
Treatments of paediatric multiple sclerosis: Efficacy and tolerance in a longitudinal follow-up study	5
Standardized motor assessments before the age of five predicting school-aged motor outcome including DCD: A systematic review	5
Migraine in childhood: Gender differences	5
The use of intrathecal baclofen for management of spasticity in hereditary spastic paraparesis: A case series	5
Duplication/triplication mosaicism of EBF3 and expansion of the EBF3 neurodevelopmental disorder phenotype	5
Management and results of epilepsy surgery associated with acyclovir prophylaxis in four pediatric patients with drug-resistant epilepsy due to herpetic encephalitis and review of the literature	5